Jonathas Xavier Pereira

Jonathas Xavier Pereira

Auto-generated profile, based on publicly available information

Jonathas Xavier Pereira

Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG) - Goiás, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TCThadeu Costa
Thadeu Costa
TPTatiana Almeida Pádua
Tatiana Almeida Pádua
JPJonathas Xavier Pereira
Jonathas Xavier Pereira
VRVinicius Gonçalves Rodrigues
Vinicius Gonçalves Rodrigues
LSLeonardo Noboru Seito
Leonardo Noboru Seito
CPCarmen Penido
Carmen Penido
Background: Glioblastoma is the most invasive and malignant brain tumor, for which no effective treatment is currently available. Heat shock protein 90 (HSP90) is a potential target for the treatment of different types of cancer. Herein, we investigated the effect of gedunin, an HSP90 inhibitor, in murine GL261 glioblastoma in vitro and in vivo models. Methods: Gedunin effects were assessed by in vitro cell viability assay (MTT), apoptosis (PI/Annexin staining), proliferation (CFSE), invasion (transmigration, scratch assay and zymography), protein detection (western blot) and in vivo orthotopic glioblastoma model (brain computed tomography and histology). Results: Gedunin treatment decreased GL261 cell proliferation and triggered apoptosis in a concentration-dependent manner. Gedunin also reduced GL261 cell migration and metalloproteinase-2 activity, suggesting that it impairs glioblastoma cell invasion. Despite the reduction of total protein content in gedunin-treated cells, the phosphorylation of STAT3 and ERK1/2 pathways was enhanced within 24 h. In situ treatment with gedunin did not significantly reduce tumor volume. Still, it reduced the tumor central area and the presence of vascular structures in xenograft glioblastoma in C57BL/6 mice, a clinical feature associated with morbidity and mortality. Conclusion: Gedunin inhibits murine glioblastoma cell growth and proliferation by inducing apoptosis. Graphical